December 30, 2022: An MOU between the OCI Foundation and “Gynius AB” (the Swedish manufacturers of the Gynocular Digital Cervical Cancer Screening Device) was recently signed in Brussels, the capital city of Belgium.
Gynius was represented by its CEO, Dr Huaquing Li. On its part, the OCI Foundation was represented by its President (Dr Chris Ifediora) and Vice President (Mrs Nkem Ifediora).
Video Summary of the Meeting, Discussions and MOU (Brussels, Belgium; 30/12/2022)
This partnership will see to the expansion of an already existing collaboration between the 2 companies, and will now include the equipping of a state-of-the-art cancer lab in Nigeria, along with supplies of more screening, diagnostic and therapeutic anti-cervical and anti-breast cancer devices.